Allogeneic stem cell transplantation as a risk factor for recurrent melanoma

Leuk Lymphoma. 2018 Jul;59(7):1750-1752. doi: 10.1080/10428194.2017.1393670. Epub 2017 Oct 31.

Authors

Hannah Stevens¹, Kavita Raj², Michael Ashby¹, Andrew Grigg¹

Affiliations

¹ a Department of Clinical Haematology , Austin Health , Melbourne , Victoria , Australia.
² b Department of Haematology , King's College Hospital , London , UK.

PMID: 29087220
DOI: 10.1080/10428194.2017.1393670

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Biopsy
Combined Modality Therapy
Female
Hematopoietic Stem Cell Transplantation* / adverse effects
Hematopoietic Stem Cell Transplantation* / methods
Humans
Male
Melanoma / diagnosis
Melanoma / diagnostic imaging
Melanoma / drug therapy*
Melanoma / pathology*
Middle Aged
Recurrence
Risk Factors
Tomography, X-Ray Computed
Transplantation, Homologous
Treatment Outcome